Trichloroethylene activates CD4+ T cells: Potential role in an autoimmune response

Drug Metabolism Reviews

Volumn 31, Issue 4, 1999, Pages 901-916

  Gilbert, Kathleen M ^a   Griffin, Joseph M ^a   Pumford, Neil R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYTOKINE; DRINKING WATER; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 4; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; HELPER CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD44; ANTIGENS, CD45; AUTOIMMUNITY; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; SOLVENTS; SPLEEN; TRICHLOROETHYLENE;

EID: 0032747613     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100101945     Document Type: Article

References (54)

1. Y. Adachi, M. Inaba, A. Sugihara, M. Koshiji, K. Sugiura, Y. Amoh, S. Mori, T. Kamiya, H. Genha, and S. Ikehara, Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW X BXSB)F1 mice, Immunobiology, 198, 451-464 (1998).
2. + T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice, Eur. J. Immunol., 22, 2387-2393 (1992).
3. C. Mauri, C. Q. Chu, D. Woodrow, L. Mori, and M. Londei, Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody, J. Immunol., 159, 5032-5041 (1997).
4. R. Merino, L. Fossati, M. Iwamoto, S. Takahashi, R. Lemoine, N. Ibnou-Zekri, L. Pugliatti, J. Merino, and S. Izui, Effect of long-term anti-CD4 or anti-CD8 treatment on the development of 1pr CD4-CD8-double negative T cells and of the autoimmune syndrome in MRL-1pr/1pr mice, J. Autoimmun., 8, 33-45 (1995).
5. J. C. Prinz, M. Meurer, E. P. Rieber, G. Plewig, and G. Riethmuller, Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412, J. Am. Acad. Dermatol., 34, 244-252 (1996).
6. L. Pelletier, R. Pasquier, J. Rosset, M. C. Vial, and P. Druet, Autoreactive T cells in mercury-induced autoimmunity. Ability to induce the autoimmune disease, J. Immunol., 140, 750-754 (1988).
7. A. Kretz-Rommel and R. L. Rubin, Persistence of autoreactive t cells drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus, J. Immunol., 162, 813-820 (1999).
8. A. Saoudi, M. Castedo, D. Nochy, C. Mandet, R. Pasquier, P. Druet, and L. Pelletier, Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polyclonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients, Eur. J. Immunol., 25, 1972-1979 (1995).
9. S. G. Paik, N. Fleischer, and S. I. Shin, Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: Obligatory role of cell-mediated autoimmune processes, Proc. Natl. Acad. Sci. USA, 77, 6129-6133 (1980).
10. P. Griem, M. Wulferink, B. Sachs, J. B. Gonzalez, and E. Gleichmann, Allergic and autoimmune reactions to xenobiotics: How do they arise? Immunol. Today, 19, 133-141 (1998).
11. J. Markeljevic, M. Marusic, B. Uzarevic, M. Petrovecki, K. Trutin-Ostovic, N. Cikes, D. Batinic, D. Babic-Naglic, and Z. Horvat, T cell subset composition in remission phase of systemic connective tissue diseases, J. Clin. Lab. Immunol., 35, 33-39 (1991).
12. Y. Ichikawa, A. Masumoto, M. Yoshida, C. Yamada, T. Horiki, Y. Hoshina, M. Uchiyama, and M. Takaya, Decay-accelerating factor (DAF, CD55)-negative T lymphocytes in the peripheral blood of Sjogren's syndrome patients, Tokai J. Exp. Clin. Med., 21, 121-128 (1996).
13. U. Fiocco, M. Rosada, L. Cozzi, C. Ortolani, G. De Silvestro, A. Ruffatti, E. Cozzi, C. Gallo, and S. Todesco, Early phenotypic activation of circulating helper memory T cells in scleroderma: Correlation with disease activity, Ann. Rheum. Dis., 52, 272-277 (1993).
14. + lymphocytes in peripheral blood of systemic lupus erythematosus can recover after separation from patient's sera, J. Dermatol. Sci., 7, 185-190 (1994).
15. M. Neidhart, K. Fehr, F. Pataki, and B. A. Michel, The levels of memory (CD45RA-, RO+) CD4+ and CD8+ peripheral blood T-lymphocytes correlate with IgM rheumatoid factors in rheumatoid arthritis, Rheumatol. Int., 15, 201-209 (1996).
16. E. B. Chu, D. N. Ernst, M. V. Hobbs, and W. O. Weigle, Maturational changes in CD4+ cell subsets and lymphokine production in BXSB mice, J. Immunol., 152, 4129-4136 (1994).
17. G. Inghirami, J. Simon, J. E. Balow, and G. C. Tsokos, Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin, Clin. Exp. Rheumatol., 6, 269-276 (1988).
18. Y. Heo, W. T. Lee, and D. A. Lawrence, In vivo the environmental pollutants lead and mercury induce oligoclonal T cell responses skewed toward type-2 reactivities, Cell. Immunol., 179, 185-195 (1997).
19. K. H. Kilburn and R. W. Washaw, Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water, Environ. Res., 57, 1-9 (1992).
20. J. A. Goldman, Connective tissue disease in people exposed to organic chemical solvents, J. Clin. Rheumatol., 2, 185-190 (1996).
21. J. E. Lockey, C. R. Kelly, G. W. Cannon, T. V. Colby, V. Aldrich, and G. K. Livingston, Progressive systemic sclerosis associated with exposure to trichloroethylene, J. Occup. Med., 29, 493-496 (1997).
22. V. S. Byers, A. S. Levin, D. M. Ozonoff, and R. W. Baldwin, Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukemia, Cancer Immunol. Immunother., 27, 77-82 (1988).
23. L. C. Clark, A. Giulano, B. Walsh, J. Guernsey de Zaplen, D. S. Alberts, J. Meister, and T. S. Manson, The Santa Cruz County Community Health Survey, Arizona Department of Health Services, Phoenix, 1994.
24. P. J. Nietert, S. E. Sutherland, R. M. Silver, J. P. Pandey, R. G. Knapp, D. G. Hoel, and M. Dosemeci, Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum., 41, 1111-1119 (1998).
25. M. F. Khan, B. S. Kaphalia, B. S. Prabhakar, M. F. Kanz, and G. A. S. Ansari, Trichloroethylene-induced autoimmune response in female MRL +/+ mice. Toxicol. Appl. Pharm., 134, 155-160 (1995).
26. R. C. Budd, J. C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R. C. Howe, and H. R. MacDonald, Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigen stimulation, J. Immunol., 138, 3120-3129 (1987).
27. + T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression, J. Immunol., 151, 575-587 (1993).
28. P. Estess, H. C. DeGrendele, V. Pascual, and M. H. Siegelman, Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity, J. Clin. Invest., 102, 1173-1182 (1998).
29. J. M. Griffin, S. J. Blossom, S. K. Jackson, K. M. Gilbert, and N. R. Pumford, Trichloroethylene accelerates an autoimmune response in association with Th1 T cell activation in MRL +/+ mice, Immunopharmacology (in press).
30. C. Haas, B. Ryffel, and M. Le Hir, IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/1pr mice, J. Immunol., 155, 5484-5491 (1997).
31. D. Balomenos, R. Rumold, and A. N. Theofilopoulos, Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-1pr mice, J. Clin. Invest., 101, 364-371 (1998).
32. B. H. Hahn and P. B. Tsao, Antibodies to DNA, in Dubois Lupus Erythematosus (F. P. Quismorio, Jr. and J. R. Klinenberg, eds.), Lea & Febiger, Philadelphia, 1993, pp. 407-422.
33. B. H. Hahn, Animal models of systemic lupus erythematosus, in Dubois' Lupus Erythematosus (F. P. Quismorio, Jr. and J. R. Klinenberg, eds.), Lea & Febiger, Philadelphia, 1993, pp. 157-177.
34. M. Croft, L. M. Bradley, and S. L. Swain, Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells, J. Immunol., 152, 2675-2685 (1994).
35. Y. Jiang and G. Moller, In vitro effects of HgC12 on murine lymphocytes. II. Selective activation of T cells expressing certain V beta TCR, Int. Immunol., 8, 1729-1736 (1996).
36. J. Fillion, R. Baccala, C. Pannetier, J. Kuhn, P. Druet, and J. Belmont, Evidence for heterogenous TCR V beta repertoire expression in mercury-induced immune disorders in rats, Int. Immunol., 9, 263-271 (1997).
37. A. P. Moghaddam, R. Abbas, J. W. Fisher, and J. C. Lipscomb, The role of mouse intestinal microflora in the metabolism of trichloroethylene, an in vivo study, Hum. Exp. Toxicol., 16, 629-635 (1997).
38. C. Guarner, B. A. Runyon, S. Young, M. Heck, and M. Y. Sheikh, Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites, J. Hepatol., 26, 1372-1380 (1997).
39. D. F. Tough, S. Sun, and J. Sprent, T cell stimulation in vivo by lipopolysaccharide (LPS), J. Exp. Med., 185, 2089-2094 (1997).
40. ++ requires 2-mercaptoethanol and lipopolysaccharide as co-factors, Immunobiology, 174, 233-243 (1999).
41. J. Rhodes, H. Chen, S. R. Hall, J. E. Beesley, D. C. Jenkins, P. Collins, and B. Zheng, Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs, Nature, 377, 71-75 (1995).
42. H. Chen, S. Hall, B. Heffernan, N. R. Thompson, M. V. Rogers, and J. Rhodes, Convergence of Schiff base costimulatory signaling and TCR signaling at the level of mitogen-activated protein kinase ERK2, J. Immunol., 159, 2274-2281 (1997).
43. A. Aruffo, I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed, CD44 is the principal cell surface receptor for hyaluronate, Cell, 61, 1303-1320 (1990).
44. A. Engstrom-Laurent, N. Feltelius, R. Hallgren, and A. Wasteson, Raised serum hyaluronate levels in scleroderma: An effect of growth factor induced activation of connective tissue cells? Ann. Rheum. Dis., 44, 614-620 (1985).
45. A. Lundin, A. Engstrom-Laurent, G. Michaelsson, and A. Tengblad, High levels of hyaluronate in suction blister fluid from active psoriatic lesions, Br. J. Dermatol., 116, 335-340 (1987).
46. A. Engstrom-Laurent and R. Hallgren, Circulating hyaluronate in rheumatoid arthritis: Relationship to inflammatory activity and the effect of corticosteroid therapy, Ann. Rheum. Dis., 44, 83-88 (1985).
47. M. Plebani, A. Giacomini, A. Floreani, M. Chiaramonte, G. Soffiati, R. Naccarato, and A. Burlina, Biochemical markers of hepatic ribrosis in primary biliary cirrhosis, Ric. Clin. Lab., 20, 269-274 (1990).
48. L. Bjermer, A. Engstrom-Laurent, M. Thunell, and R. Hallgren, Hyaluronic acid in bronchoalveolar lavage fluid in patients with sarcoidosis: Relationship to lavage mast cells, Thorax, 42, 933-938 (1987).
49. G. Tornling, A. Engstrom-Laurent, R. Hallgren, G. Unge, and B. Westman, Hyaluronic acid in bronchoalveolar lavage in rats exposed to quartz, Br. J. Ind. Med., 44, 443-445 (1987).
50. P. M. Bartold, Platelet-derived growth factor stimulates hyaluronate but not proteoglycan synthesis by human gingival fibroblasts in vitro, J. Dent. Res., 72, 1473-1480 (1993).
51. P. M. Bartold, The effect of interleukin-1β on hyaluronic acid synthesized by adult human gingival fibroblasts in vitro, J. Periodont. Res., 23, 139-147 (1991).
52. J. R. Fraser, T. C. Laurent, and U. B. Laurent, Hyaluronan: its nature, distribution, functions and turnover, J. Intern. Med., 242, 27-32 (1997).
53. R. Galandrini, E. Galluzzo, N. Albi, C. E. Grossi, and A. Verlardi, Hyaluronate is costimulatory for human T cell effector functions and bind to CD44 on activated T cells, J. Immunol., 153, 21-31 (1994).
54. N. C. Halmes, D. C. McMillan, J. E. Oatis, and N. R. Pumford, Immunochemical detection of protein adducts in mice treated with trichloroethylene, Chem. Res. Toxicol., 9, 451-458 (1996).